Advertisement
Advertisement
MLAB
Mesa Laboratories Inc
125.11
USDSponsored
+5.81
+4.87%
Nov 06, 11:35 UTC -5
Open
Mesa Laboratories Inc (MLAB) Earnings
MLAB Earnings Reports
Positive Surprise Ratio
MLAB beat 21 of 42 last estimates.
50%
Next Report
Next Week
Date of Next Report
Nov 09, 2026
Estimate for Q2 27 (Revenue/ EPS)
$63.44M
/$0.36
Implied change from Q1 27 (Revenue/ EPS)
+5.50%
/-26.53%
Implied change from Q2 26 (Revenue/ EPS)
+5.50%
/-20.00%
Mesa Laboratories Inc earnings per share and revenue
On Aug 10, 2026, MLAB reported earnings of 0.49 USD per share (EPS) for Q1 27, beating the estimate of 0.03 USD, resulting in a 1501.31% surprise. Revenue reached 60.14 million, compared to an expected 62.08 million, with a -3.13% difference. The market reacted with a +9.46% price change (close before vs. close after earnings).
Looking ahead to Q2 27, 4 analysts forecast an EPS of 0.36 USD, with revenue projected to reach 63.44 million USD, implying an decrease of -26.53% EPS, and increase of 5.50% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
FAQ
What were Mesa Laboratories Inc's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Mesa Laboratories Inc reported EPS of $0.49, beating estimates by 1501.31%, and revenue of $60.14M, -3.13% below expectations.
How did the market react to Mesa Laboratories Inc's Q1 2027 earnings?
The stock price moved up 9.46%, changed from $101.62 before the earnings release to $111.23 the day after.
When is Mesa Laboratories Inc expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Mesa Laboratories Inc's next earnings report?
Based on 4
analysts, Mesa Laboratories Inc is expected to report EPS of $0.36 and revenue of $63.44M for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.